Approach to the Patient With Short Stature: Genetic Testing

J Clin Endocrinol Metab. 2023 Mar 10;108(4):1007-1017. doi: 10.1210/clinem/dgac637.

Abstract

The first step in the evaluation of the short child is to decide whether growth parameters in the context of the history are abnormal or a variant of normal. If growth is considered abnormal, system and hormonal tests are likely to be required, followed by more directed testing, such as skeletal survey and/or genetic screening with karyotype or microarray. In a small percentage of short children in whom a diagnosis has not been reached, this will need to be followed by detailed genetic analysis; currently, exome sequencing using targeted panels relevant to the phenotype is the commonly used test. Clinical scenarios are presented that illustrate how such genetic testing can be used to establish a molecular diagnosis, and how that diagnosis contributes to the management of the short child. New genetic causes for short stature are being recognized on a frequent basis, while the clinical spectrum for known genes is being extended. We recommend that an international repository for short stature conditions is established for new findings to aid dissemination of knowledge, but also to help in the definition of the clinical spectrum both for new and established conditions.

Keywords: genetic testing; molecular diagnosis; short stature.

MeSH terms

  • Dwarfism* / diagnosis
  • Dwarfism* / genetics
  • Exome Sequencing
  • Genetic Testing*
  • Humans
  • Karyotype
  • Phenotype